Melanie Preston

0 Flares 0 Flares × The medical centre at Kibbutz Be’eri, where at least five people were murdered Oct. 7, 2023. (photo by Melanie Preston) I’m sitting in the dining hall at Kibbutz Be’eri, as people begin to enter for their Sunday lunch at 11:39 a.m. Sunday is like Monday here in Israel, the work week being Sunday through Thursday. I’d never spent time on a kibbutz until now, except for a few days on my Birthright trip, which was my introduction to Israel.

0 Flares 0 Flares × Clockwise from top left: Carmel Gat, Hersh Goldberg-Polin, Eden Yerushalmi, Alex Lubanov, Ori Danino, Almog Sarusi. (photos from internet). This article is an edited version of a blog posted on Sept. 2, 2024. Carmel Gat, Hersh Goldberg-Polin, Eden Yerushalmi, Alex Lubanov, Ori Danino, Almog Sarusi. The cursor has been blinking below these six names and faces.

1 BACKGROUND There is no cure or vaccine for human T-cell lymphotropic virus type 1 (HTLV-1). In England and Wales, approximately 22,000 people live with HTLV-1,1 the majority are women (65%), of Black Caribbean ethnicity (60%) and born outside the United Kingdom (72%).2 This underserved community of people living with a rare condition were empowered to identify their research priorities.